Biological Response Modifiers Committee
Executive Summary
March 20 and 21 meeting will address issues related to use of human pancreatic islets for the treatment of diabetes. The committee will also hear a report of the Jan. 13 meeting of the Xenotransplantation Committee and an update on FDA research programs. The meeting will take place at the Holiday Inn in Bethesda, Md. beginning at 8 a.m